AJMC December 15, 2022
Allison Inserro

The dilemma of Alzheimer disease in primary care, as well as other health challenges in aging populations, was the focus of a recent Institute for Value-Based Medicine® event in Portland, Oregon.

Am J Accountable Care. 2022;10(4):47-49. https://doi.org/10.37765/ajac.2022.89289

Cognitive concerns frequently show up in primary care as adults age, although not all memory loss will progress to the dysfunction of dementia. However, the number of Americans with diagnosed Alzheimer disease (AD) could grow to nearly 14 million by 2060, up from 6.5 million currently.1

To halt that trend, much of the recent focus has been on the success or failure of drugs to slow the progression of this devastating neurological disease, most notably the FDA’s controversial 2021 approval of aducanumab, a...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Healthcare System, Payment Models, Population Health Mgmt, Primary care, Provider, Value Based
Health care waste exposed [PODCAST]
Finger on the Pulse: The State of Primary Care in the U.S. and Nine Other Countries
Physician Compensation Continues To Decline, Despite A Dire Shortage
Walgreens Suffers $6 Billion Loss As VillageMD Clinic Investment Sours
Study: Primary care physicians ‘stretched too thin’ to take on additional research

Share This Article